Hematologic - Articles - Page 66

Vadadustat approved in Japan for the treatment of anemia due to CKD

June 30, 2020

Japan first to approve Duvroq for anemia due to chronic kidney disease

June 29, 2020

European Commission approves Ultomiris for adults and children with aHUS

June 29, 2020

Reblozyl approved in Europe for transfusion-dependent anemia in MDS or beta-thalassemia

June 29, 2020

First clinical results presented for PXS-5505

June 18, 2020

Pfizer describes new hemoglobin subunit beta polymerization inhibitors

June 17, 2020

Astellas reports positive results for roxadustat phase III study

June 16, 2020

By Gina Lee

HONG KONG – Astellas Pharma Inc. reported positive results from phase III of its DOLOMITES study comparing the efficacy and safety of roxadustat to that of darbepoetin alfa in treating anemia in nondialysis-dependent, stage 3 to 5 chronic kidney disease (CKD) patients.

Astellas reports positive results for roxadustat phase III study

June 10, 2020

By Gina Lee

HONG KONG – Astellas Pharma Inc. reported positive results from phase III of its DOLOMITES study comparing the efficacy and safety of roxadustat to that of darbepoetin alfa in treating anemia in nondialysis-dependent, stage 3 to 5 chronic kidney disease (CKD) patients.